Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ACADIA PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 205,433 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $5.5M as of 2025-Q4. The position was decreased (-2.7% shares). ACAD represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$5.5M
Current Shares
205,433
Total Value Change
+$2M
Total Shares Change
-12,162
Other major holders of ACAD: CAPITAL FUND MANAGEMENT S.A., BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Decreased |
| 205,433 |
-2.7% |
| $5.5M |
| 0.0% |
| $26.70 |
0 |
| 2025-Q3 | Decreased | 211,115 | -38.4% | $4.5M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Increased | 342,882 | +36.6% | $7.4M | 0.0% | $22.12 | 36 |
| 2025-Q1 | Increased | 251,056 | +14.6% | $4.2M | 0.0% | $17.07 | 31 |
| 2024-Q4 | Increased | 219,125 | +15.5% | $4M | 0.0% | $16.69 | 31 |
| 2024-Q3 | Decreased | 189,739 | -12.8% | $2.9M | 0.0% | $15.69 | 0 |
| 2024-Q2 | Increased | 217,595 | +82.3% | $3.5M | 0.0% | $16.25 | 41 |